89 related articles for article (PubMed ID: 21552929)
1. Molecular abnormalities of mdm-2 in human sarcomas.
Buesoramos C; Yang Y; Manshouri T; Feltz L; Ayala A; Glassman A; Albitar M
Int J Oncol; 1995 Nov; 7(5):1043-8. PubMed ID: 21552929
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of MDM-2 in breast carcinomas.
Bueso-Ramos CE; Manshouri T; Haidar MA; Yang Y; McCown P; Ordonez N; Glassman A; Sneige N; Albitar M
Breast Cancer Res Treat; 1996; 37(2):179-88. PubMed ID: 8750585
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
Olson DC; Marechal V; Momand J; Chen J; Romocki C; Levine AJ
Oncogene; 1993 Sep; 8(9):2353-60. PubMed ID: 7689721
[TBL] [Abstract][Full Text] [Related]
4. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
Stefanou DG; Nonni AV; Agnantis NJ; Athanassiadou SE; Briassoulis E; Pavlidis N
Anticancer Res; 1998; 18(6B):4673-81. PubMed ID: 9891539
[TBL] [Abstract][Full Text] [Related]
5. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance.
Haidar MA; El-Hajj H; Bueso-Ramos CE; Manshouri T; Glassman A; Keating MJ; Maher A
Am J Hematol; 1997 Mar; 54(3):189-95. PubMed ID: 9067496
[TBL] [Abstract][Full Text] [Related]
6. The human MDM-2 oncogene is overexpressed in leukemias.
Bueso-Ramos CE; Yang Y; deLeon E; McCown P; Stass SA; Albitar M
Blood; 1993 Nov; 82(9):2617-23. PubMed ID: 8219216
[TBL] [Abstract][Full Text] [Related]
7. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
[TBL] [Abstract][Full Text] [Related]
8. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
Flørenes VA; Maelandsmo GM; Forus A; Andreassen A; Myklebost O; Fodstad O
J Natl Cancer Inst; 1994 Sep; 86(17):1297-302. PubMed ID: 8064888
[TBL] [Abstract][Full Text] [Related]
9. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
[TBL] [Abstract][Full Text] [Related]
10. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
12. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma.
Gorgoulis VG; Zoumpourlis V; Rassidakis GZ; Karameris A; Rassidakis AN; Spandidos DA; Kittas C
J Pathol; 1996 Oct; 180(2):129-37. PubMed ID: 8976869
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MDM4 (MDMX) function by p76(MDM2): a new facet in the control of p53 activity.
Giglio S; Mancini F; Pellegrino M; Di Conza G; Puxeddu E; Sacchi A; Pontecorvi A; Moretti F
Oncogene; 2010 Nov; 29(44):5935-45. PubMed ID: 20697359
[TBL] [Abstract][Full Text] [Related]
14. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
15. MDM-2 oncoprotein overexpression, p53 gene mutation, and VEGF up-regulation in angiosarcomas.
Zietz C; Rössle M; Haas C; Sendelhofert A; Hirschmann A; Stürzl M; Löhrs U
Am J Pathol; 1998 Nov; 153(5):1425-33. PubMed ID: 9811333
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
17. Expression of mdm-2 oncoprotein in the primary and metastatic sites of mammary tumor (GI-101) implanted athymic nude mice.
Rathinavelu P; Malavé A; Raney SR; Hurst J; Roberson CT; Rathinavelu A
Cancer Biochem Biophys; 1999 Jul; 17(1-2):133-46. PubMed ID: 10738909
[TBL] [Abstract][Full Text] [Related]
18. mdm-2 expression in human testicular germ-cell tumors and its clinical value.
Eid H; Institoris E; Géczi L; Bodrogi I; Bak M
Anticancer Res; 1999; 19(4C):3485-90. PubMed ID: 10629640
[TBL] [Abstract][Full Text] [Related]
19. mdm-2 gene amplification in 3T3-L1 preadipocytes.
Berberich SJ; Litteral V; Mayo LD; Tabesh D; Morris D
Differentiation; 1999 May; 64(4):205-12. PubMed ID: 10365438
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]